Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure…
Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure
Overview of attention for article published in Journal of Clinical Oncology, November 2016
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
High Attention Score compared to outputs of the same age and source (80th percentile)
Mentioned by
- news
- 6 news outlets
- policy
- 1 policy source
- 28 X users
- googleplus
- 1 Google+ user
- guideline
- 2 clinical guideline sources
Readers on
- mendeley
- 377 Mendeley